CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
Lead CVS Caremark will restore coverage for Eli Lilly’s weight-loss drug Zepbound this year, the drugmaker said Thursday, reversing a removal that drew patient complaints and a class-action lawsuit. The drug is scheduled to return to CVS Caremark’s standard formulary by Oct. 1, and some privately insured patients could see copays as low as $25. … Read more